Rontis
↗Zug, Switzerland
Rontis is a multinational healthcare corporation headquartered in Switzerland, with a history dating back to 1986. The company operates as a diversified healthcare provider, specializing in the research, development, manufacturing, and distribution of medical devices, pharmaceutical products, infant nutrition, and consumer healthcare/dermaceutical products.
In the medical device sector, Rontis focuses heavily on interventional cardiology and peripheral vascular products, including drug-eluting stents, balloons, and guide wires. The company has invested in state-of-the-art manufacturing facilities and in-house R&D laboratories to support its transition from a distributor to a manufacturer of specialty healthcare solutions.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Interventional Cardiology and Peripheral Vascular
SIZE & FINANCIALS
Employees:501-1000
Founded:1986
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Medical Device focus)
Modalities:Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Rontis Hellas S.A.
COMPETITION
Position:Niche Player
Competitors:SMT, Aortyx, Terumo Medical, Stryker
LEADERSHIP
Key Executives:
Efi Soultou - Managing Director
Anastasios Politopoulos - VP International Business Development
Periklis Vasilopoulos - Board Member
LINKS
Website:rontis.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Rontis and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rontis. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.